N. Bhatia

发表

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.

B. Elewski, J. Schlessinger, M. Gold, 2020 .

Understanding Genital Warts: Epidemiology, Pathogenesis, and Burden of Disease of Human Papillomavirus

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.

O. Akilov, O. Donini, T. Kuzel, 2022, JAMA dermatology.

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study†

L. Denis, S. Forman, J. Fowler, 2019, The British journal of dermatology.

Evidence‐based recommendations for the management of acne fulminans and its variants

J. Leyden, M. Levin, D. Thiboutot, 2017, Journal of the American Academy of Dermatology.

Evolving perspectives on the etiology and pathogenesis of acne vulgaris.

J. Weiss, L. Eichenfield, L. Kircik, 2015, Journal of drugs in dermatology : JDD.

Optimal management of papulopustular rosacea: rationale for combination therapy.

J. D. Del Rosso, N. Bhatia, 2012, Journal of drugs in dermatology : JDD.

Oracea 40 mg Capsules for Papulopustular Rosacea

N. Bhatia, 2013 .

Oral Antibiotics for Acne

N. Bhatia, Dillon J. Patel, 2020, American Journal of Clinical Dermatology.

Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.

J. D. Del Rosso, N. Bhatia, 2011, Cutis.

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.

I. Stuart, L. Kircik, L. Stein Gold, 2020, The Journal of clinical and aesthetic dermatology.

Minocycline 1.5% Foam for the Topical Treatment of Moderate-to-Severe Papulopustular Rosacea: Results of Two Phase 3, Randomized, Clinical Trials.

I. Stuart, L. Kircik, J. D. Del Rosso, 2020, Journal of the American Academy of Dermatology.

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3

J. Silverberg, M. Gooderham, A. Blauvelt, 2022, Dermatology and Therapy.

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.

M. Lebwohl, Z. Draelos, M. Gooderham, 2022, JAMA.

Actinic Keratosis: Current Therapies and Insights Into New Treatments

D. Rigel, L. Kircik, N. Bhatia, 2019, Journal of drugs in dermatology : JDD.

Polypodium leucotomos: A Potential New Photoprotective Agent

N. Bhatia, 2015, American Journal of Clinical Dermatology.

Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature.

R. Ceilley, I. Hamzavi, N. Bhatia, 2014, Journal of drugs in dermatology : JDD.

The Dermatologist’s Approach to Onychomycosis

N. Bhatia, Jenna N Queller, 2015, Journal of fungi.

Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape.

T. Rosen, L. Kircik, S. Friedlander, 2015, Journal of drugs in dermatology : JDD.

Onychomycosis: Strategies to Minimize Recurrence.

B. Elewski, A. Tosti, T. Rosen, 2016, Journal of drugs in dermatology : JDD.

Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™.

D. Furst, K. Gordon, C. Leonardi, 2017, Seminars in cutaneous medicine and surgery.

Cutaneous fungal infections are commonly misdiagnosed: A survey‐based study

A. Friedman, N. Bhatia, R. Yadgar, 2017, Journal of the American Academy of Dermatology.

Treating seborrheic dermatitis: review of mechanisms and therapeutic options.

N. Bhatia, 2013, Journal of drugs in dermatology : JDD.

A Phase IIb, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Plaque Psoriasis: Secondary Efficacy and Patient-Reported Outcomes.

L. Gold, A. Tallman, N. Bhatia, 2020, Journal of the American Academy of Dermatology.

Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy

D. Rigel, Justin W Marson, J. D. Del Rosso, 2021 .

Onychomycosis: Does Cure Equate to Treatment Success?

B. Elewski, A. Tosti, T. Rosen, 2016, Journal of drugs in dermatology : JDD.

Managing Assessments and Expectations: Patient Responses Following Therapy With Efinaconazole Topical Solution, 10%.

N. Bhatia, 2015, Journal of drugs in dermatology : JDD.

Imiquimod as a possible treatment for keratoacanthoma.

N. Bhatia, 2004, Journal of drugs in dermatology : JDD.

Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects

Shilpi Jain, N. Bhatia, V. Yadav, 2020, Clinical Drug Investigation.

Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.

D. Goldberg, B. Berman, R. Ceilley, 2017, Journal of drugs in dermatology : JDD.

A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance.

J. D. Del Rosso, N. Bhatia, J. Bikowski, 2007, Journal of drugs in dermatology : JDD.

A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup.

L. Kircik, E. Guenin, N. Bhatia, 2020, The Journal of clinical and aesthetic dermatology.

Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/Ethnicity.

N. Sadick, S. Tyring, J. Weiss, 2020, Journal of drugs in dermatology : JDD.

Randomized, Observer-blind, Split-face Compatibility Study with Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% gel and Facial Foundation Makeup.

N. Bhatia, R. Pillai, 2015, The Journal of clinical and aesthetic dermatology.

Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations

F. Fenton, E. Cherry, H. Ashikaga, 2021, Heart rhythm O2.

Study ( Year ) Design Regimen 1 Regimen 2 Duration Results

N. Bhatia, J. Bikowski, 2010 .

Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population.

E. Guenin, N. Bhatia, W. Werschler, 2020, Cutis.

Therapeutic Options for External Genital Warts

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

Efficacy and Safety of Topical Sofpironium Bromide Gel for the Treatment of Axillary Hyperhidrosis: A Phase II, Randomized, Controlled, Double-Blinded Trial.

Ping-Yu Liu, L. Baumann, Joel L Cohen, 2020, Journal of the American Academy of Dermatology.

EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MILD TO MODERATE PLAQUE PSORIASIS: RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.

M. Gooderham, K. Papp, D. Pariser, 2021, Journal of the American Academy of Dermatology.

Clinical Features of External Genital Warts

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion

M. Lebwohl, L. Gold, N. Bhatia, 2020, SKIN The Journal of Cutaneous Medicine.

A Comparison of the Clinical Effectiveness and Cost-Effectiveness of Treatments for Moderate to Severe Psoriasis

A. Bronstone, G. Goldenberg, J. Dunn, 2010 .

17800 Open-label extension study evaluating the long-term safety, efficacy, and tolerability of FMX103 1.5% topical minocycline foam in the treatment of moderate to severe facial papulopustular rosacea

I. Stuart, L. Kircik, D. Hooper, 2020, Journal of the American Academy of Dermatology.

LB784 Acne fulminans and its variants: Evidence-based expert panel recommendations

J. Leyden, M. Levin, D. Thiboutot, 2016 .

Efficacy of aminolevulinic acid 20% solution combined with photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial.

D. Piacquadio, D. Siegel, B. Berman, 2020, Photodiagnosis and photodynamic therapy.

Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

N. Zeitouni, D. Siegel, R. Ceilley, 2021, The Journal of clinical and aesthetic dermatology.

Management of Actinic Keratosis

N. Bhatia, 2017, Current Dermatology Reports.

Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis.

J. G. Vásquez, N. Bhatia, B. Schenkel, 2023, The Journal of dermatological treatment.

Photodynamic Therapy in 2020: Lights in the Darkness

N. Bhatia, 2020 .

Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

M. Lebwohl, Z. Draelos, M. Gooderham, 2021, SKIN The Journal of Cutaneous Medicine.

Local skin reactions and the onset of influenza-like signs and symptoms induced by imiquimod

N. Bhatia, 2022, JAAD international.

Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies

M. Lebwohl, A. Grada, B. Berman, 2020 .

Status Report on Topical Hypochlorous Acid: Clinical Relevance of Specific Formulations, Potential Modes of Action, and Study Outcomes.

J. D. Del Rosso, N. Bhatia, 2018, ˜The œJournal of clinical and aesthetic dermatology.

Topical Vehicle Formulations in the Treatment of Acne.

L. Kircik, L. Hoffman, J. Zeichner, 2018, Journal of drugs in dermatology : JDD.

16089 Safety of ATI-502, a novel topical JAK1/3 inhibitor, in adults with moderate to severe atopic dermatitis: Results from a phase 2a open-label trial

N. Bhatia, S. D. Shanler, R. Demoor, 2020 .

The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study

L. Ferris, Z. Draelos, M. Gooderham, 2020, SKIN The Journal of Cutaneous Medicine.

Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream.

L. Kircik, D. Pariser, N. Bhatia, 2018, The Journal of clinical and aesthetic dermatology.

The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin Barrier.

S. Seité, A. Friedman, H. Baldwin, 2017, Journal of drugs in dermatology : JDD.

Overview of HPV-related Dermatoses and Applications of Sinecatechins Ointment

N. Bhatia, 2012, Current Dermatology Reports.

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies

M. Praestegaard, P. Arenberger, L. Stein Gold, 2023, Dermatology and Therapy.

Supplement Article: The Role of Epidermal Barrier Dysfunction and Cutaneous Microbiome Dysbiosis in the Pathogenesis and Management of Acne Vulgaris and Rosacea.

E. Graber, Brook E. Tlougan, P. Lio, 2022, Journal of drugs in dermatology : JDD.

Understanding the Role of Photolyases: Photoprotection and Beyond.

B. Berman, R. Ceilley, L. Kircik, 2017, Journal of Drugs in Dermatology.

Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis.

R. Gill, D. Bagchi, R. Jain, 2004, International journal of clinical pharmacology research.

Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study

A. Paller, L. Parish, D. Moreno-Ramírez, 2022, Journal of the American Academy of Dermatology.

Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies

N. Sadick, I. Stuart, L. Kircik, 2020, SKIN The Journal of Cutaneous Medicine.

Topical immunomodulation: modes of action with clinical correlation.

N. Bhatia, 2007, Dermatologic clinics.

Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study)

D. Rigel, L. Kircik, I. Kasujee, 2023, SKIN The Journal of Cutaneous Medicine.

Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study)

D. Rigel, L. Kircik, I. Kasujee, 2023, SKIN The Journal of Cutaneous Medicine.

Managing External Genital Warts: Practical Aspects of Treatment and Prevention

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report.

M. Lebwohl, A. Armstrong, D. Rigel, 2021, Journal of drugs in dermatology : JDD.